Go to myHPBInternational Hepato-Pancreato-Biliary Association
IHPBA News
-
Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres® Y-90 resin microspheres
Physicians and employees recognized for their role in this milestone and impact made on patient lives WOBURN, Mass. (June 20, 2019) –– Sirtex Medical, a leading manufacturer of...
Published
Read more -
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 resin microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic...
Published
Read more -
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease...
Published
Read more -
SIR-Spheres® Y-90 Resin Microspheres Showed no Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds
Final Results of SIRveNIB Study presented at 2017 American Society of Clinical Oncology Meeting Chicago, IL, USA (5 June 2017) -- For the second time in less than two months, a major head-to-head...
Published
Read more -
Metastatic colorectal cancer patients treated first-line with SIR-Spheres® Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, REsect study shows
Surgeons’ blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases treated in the SIRFLOX study presented at 12th Annual...
Published
Read more -
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., March 14, 2017 (GLOBE NEWSWIRE) - - AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease...
Published
Read more -
Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows
Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows 606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (?70...
Published
Read more -
Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy (SIRT) for Patients with Colorectal Liver Metastases Who Have Failed Prior Treatment
Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy (SIRT) for Patients with Colorectal Liver Metastases Who Have Failed Prior Treatment Bonn, Germany...
Published
Read more -
Leading South African Health Insurer Approves Reimbursement of SIR-Spheres® Y-90 resin microspheres for Patients with Liver Tumours
Leading South African Health Insurer Approves Reimbursement of SIR-Spheres® Y-90 resin microspheres for Patients with Liver Tumours Bonn, Germany (12 May 2016) – Sirtex (ASX:SRX) announced that...
Published
Read more -
SIRFLOX Study Published in Journal of Clinical Oncology
SIRFLOX Study Published in Journal of Clinical Oncology Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the Management of Metastatic...
Published
Read more
Corporate Partners
If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org
Find out more
